Literature DB >> 25843684

Development of approaches to induce puberty in cultured female sablefish (Anoplopoma fimbria).

José M Guzmán1, J Adam Luckenbach2, Denis A M da Silva3, Gina M Ylitalo3, Penny Swanson2.   

Abstract

Efforts to establish sustainable and efficient aquaculture production of sablefish (Anoplopoma fimbria) have been constrained by delayed puberty in cultured females. This study integrates a series of experiments aimed at gaining an understanding of the reproductive physiology of puberty in female sablefish. We detected transcripts for the dopamine D2 receptor (drd2) in brain, pituitary and ovary of sablefish, and prepubertal females exhibited significantly elevated brain and pituitary drd2 expression relative to wild maturing females. Treatments with sustained-release cholesterol pellets containing testosterone (T) and the dopamine D2 receptor antagonist, metoclopramide (Met), stimulated expression of pituitary luteinizing hormone beta subunit (lhb) and follicle-stimulating hormone beta subunit (fshb), respectively, in prepubertal females, whereas a combination of T and gonadotropin-releasing hormone agonist (GnRHa) had a strong synergistic effect on lhb expression (2000-fold higher than control). Although T induced a significant increase in the maximum ovarian follicle volume, none of the treatments tested stimulated onset of vitellogenesis. Using liquid chromatography/tandem mass spectrometry, we demonstrated that Met stimulated production of T by previtellogenic ovarian follicles in vitro, whereas gonadotropin preparations enhanced 17α-hydroxyprogesterone, androstenedione (A4), T and 17β-estradiol (E2) production. Treatment with T increased production of A4, 11β-hydroxyandrostenedione, 11β-hydroxytestosterone, E2, 11-ketotestosterone, and 5α-dihydrotestosterone (DHT). Interestingly, in the presence of high doses of T the previtellogenic ovary preferentially produced A4 and DHT over any other metabolite. Our data suggest the existence of dopamine inhibition of the reproductive axis in female sablefish. Treatments with Met and T elevated gonadotropin mRNAs in prepubertal females but failed to stimulate the transition into vitellogenic growth, suggesting a possible failure in pituitary gonadotropin protein synthesis/release. Previtellogenic ovarian follicles of sablefish are equipped to synthesize steroids, including those required for vitellogenic growth, and DHT, a steroid hormone whose role in reproduction of fishes remains unknown.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Androgens; DHT; Dopamine; GnRHa; Gonadotropins; Puberty

Mesh:

Substances:

Year:  2015        PMID: 25843684     DOI: 10.1016/j.ygcen.2015.02.024

Source DB:  PubMed          Journal:  Gen Comp Endocrinol        ISSN: 0016-6480            Impact factor:   2.822


  4 in total

1.  Gonadal sex differentiation and effects of dietary methyltestosterone treatment in sablefish (Anoplopoma fimbria).

Authors:  J Adam Luckenbach; William T Fairgrieve
Journal:  Fish Physiol Biochem       Date:  2015-09-23       Impact factor: 2.794

Review 2.  Direct and Indirect Effects of Sex Steroids on Gonadotrope Cell Plasticity in the Teleost Fish Pituitary.

Authors:  Romain Fontaine; Muhammad Rahmad Royan; Kristine von Krogh; Finn-Arne Weltzien; Dianne M Baker
Journal:  Front Endocrinol (Lausanne)       Date:  2020-12-07       Impact factor: 5.555

3.  Gonadotropins in the Russian Sturgeon: Their Role in Steroid Secretion and the Effect of Hormonal Treatment on Their Secretion.

Authors:  Svetlana Yom-Din; Lian Hollander-Cohen; Joseph Aizen; Benjamin Boehm; Michal Shpilman; Matan Golan; Avshalom Hurvitz; Gad Degani; Berta Levavi-Sivan
Journal:  PLoS One       Date:  2016-09-13       Impact factor: 3.240

4.  Reproductive life history of sablefish (Anoplopoma fimbria) from the U.S. Washington coast.

Authors:  José M Guzmán; J Adam Luckenbach; Mollie A Middleton; Kenneth C Massee; Cortney Jensen; Frederick W Goetz; Andrew J Jasonowicz; Penny Swanson
Journal:  PLoS One       Date:  2017-09-08       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.